东方农商银行再增“投贷联动”赋能新医药产业

Core Insights - Dongfang Rural Commercial Bank is aligning with the Lianyungang municipal government's goal of building the "Chinese Medicine Port" by focusing on the new pharmaceutical industry as a key area for credit support [1] - The bank has innovated a "loan-investment linkage" model to increase credit funding, providing financial assistance for high-quality industrial development [1] Summary by Categories Financial Support Initiatives - The bank has introduced the "Chenghui Rong" special credit product to address the common challenges faced by early-stage and growth-stage pharmaceutical companies, such as high R&D investment and low fixed asset ratios [1] - On September 11, the bank's development zone branch issued a loan of 5 million yuan to Jiangsu Mingyi Intelligent Manufacturing Technology Co., Ltd., and on September 12, the Yanhua branch provided a loan of 10 million yuan to Jiangsu Beimei Pharmaceutical Co., Ltd., totaling 15 million yuan [1] Impact on Pharmaceutical Companies - As of September 15, the bank has successfully implemented the "loan-investment linkage" business for four new pharmaceutical enterprises, amounting to 27 million yuan, effectively alleviating financial pressure and accelerating the conversion of technological achievements into industrial applications [1] Future Plans - Dongfang Rural Commercial Bank plans to continue focusing on the new pharmaceutical industry cluster in the city, promoting deep integration of "loan-investment linkage" with industrial chain finance, and providing credit support to upstream and downstream enterprises related to "chain master enterprises" [1]